Ignite Creation Date:
2024-07-17 @ 12:02 PM
Last Modification Date:
2024-10-26 @ 3:34 PM
Study NCT ID:
NCT06498518
Status:
RECRUITING
Last Update Posted:
2024-07-12
First Post:
2024-07-02
Brief Title:
A Trial of Gemcitabine Pembrolizumab and IMM-101 as First Line Treatment in Patients With Metastatic Pancreatic Cancer
Sponsor:
Organization:
University of Glasgow